Literature DB >> 1831066

Isolation and initial characterization of mouse tumor cells resistant to porphyrin-mediated photodynamic therapy.

M C Luna1, C J Gomer.   

Abstract

Photodynamic therapy (PDT)-resistant variants of the RIF-1 mouse tumor cell line have been isolated following a protocol of repeated porphyrin incubation and light treatments. Two porphyrin incubation procedures, employing either an extended (16 h) or a short (1 h) incubation, were used in order to obtain cell strains exposed to conditions with differing intracellular photosensitizer localization. Two clones from each PDT porphyrin incubation protocol were selected for in vitro and in vivo analyses based on degree of resistance and plating efficiency. Resistant variants had increased protein content and were larger than the parental RIF-1 cells. In vitro growth rates were similar for all cell strains. Both 16-h PDT-resistant variants exhibited modest resistance to ionizing radiation and one of the 16-h PDT-resistant variants demonstrated increased sensitivity to hyperthermia. The PDT-resistant variants did not exhibit a multidrug resistance phenotype nor did they have altered porphyrin uptake properties. The parental and resistant RIF cells had comparable basal levels of antioxidant enzymes, reduced glutathione and stress proteins, but the number of cells required to produce in vivo tumor growth in 50% of inoculated animals was increased for all PDT-resistant variants. The resistant cells exhibit a stable phenotype and should be useful in studies designed to define PDT mechanisms of action.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1831066

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

Review 1.  Mechanisms of resistance to photodynamic therapy.

Authors:  A Casas; G Di Venosa; T Hasan
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

Review 2.  The role of photodynamic therapy in overcoming cancer drug resistance.

Authors:  Bryan Q Spring; Imran Rizvi; Nan Xu; Tayyaba Hasan
Journal:  Photochem Photobiol Sci       Date:  2015-04-09       Impact factor: 3.982

Review 3.  Apoptosis and associated phenomena as a determinants of the efficacy of photodynamic therapy.

Authors:  David Kessel
Journal:  Photochem Photobiol Sci       Date:  2015-01-05       Impact factor: 3.982

4.  Luciferase-Rose Bengal conjugates for singlet oxygen generation by bioluminescence resonance energy transfer.

Authors:  Seonghoon Kim; HyeongChan Jo; Mijeong Jeon; Myung-Gyu Choi; Sei Kwang Hahn; Seok-Hyun Yun
Journal:  Chem Commun (Camb)       Date:  2017-04-20       Impact factor: 6.222

5.  Characterisation of resistance mechanisms developed by basal cell carcinoma cells in response to repeated cycles of Photodynamic Therapy.

Authors:  Silvia Rocio Lucena; Alicia Zamarrón; Elisa Carrasco; Miguel Angel Marigil; Marta Mascaraque; Montserrat Fernández-Guarino; Yolanda Gilaberte; Salvador González; Angeles Juarranz
Journal:  Sci Rep       Date:  2019-03-18       Impact factor: 4.379

6.  Characterization of resistant MCF-7 breast cancer cells developed by repeated cycles of photodynamic therapy.

Authors:  Eric Chekwube Aniogo; Blassan P George; Heidi Abrahamse
Journal:  Front Pharmacol       Date:  2022-09-16       Impact factor: 5.988

7.  In vitro studies on the potential use of 5-aminolaevulinic acid-mediated photodynamic therapy for gynaecological tumours.

Authors:  F M Rossi; D L Campbell; R H Pottier; J C Kennedy; E F Dickson
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640

Review 8.  Molecular Effectors of Photodynamic Therapy-Mediated Resistance to Cancer Cells.

Authors:  Eric Chekwube Aniogo; Blassan P George; Heidi Abrahamse
Journal:  Int J Mol Sci       Date:  2021-12-07       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.